Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001129928-25-000017
Filing Date
2025-03-07
Accepted
2025-03-07 07:41:17
Documents
2
Period of Report
2025-03-07

Document Format Files

Seq Description Document Type Size
1 6-K form6kq4-24financialresults.htm 6-K 18203
2 EX-99.1 oncyq4-24pr.htm EX-99.1 208241
  Complete submission text file 0001129928-25-000017.txt   227439
Mailing Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5
Business Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38512 | Film No.: 25717591
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)